Home  |  Contact

UniProtKB/Swiss-Prot P07148: Variant p.Thr94Ala

Fatty acid-binding protein, liver
Gene: FABP1
Variant information

Variant position:  94
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Polymorphism
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Threonine (T) to Alanine (A) at position 94 (T94A, p.Thr94Ala).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (T) to small size and hydrophobic (A)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  Polymorphism; increases the binding for cholesterol; increases high density lipoprotein (HDL)- and low density lipoprotein (LDL)-mediated cholesterol uptake.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  94
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  127
The length of the canonical sequence.

Location on the sequence:   MTGEKVKTVVQLEGDNKLVT  T FKNIKSVTELNGDIITNTMT
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 127 Fatty acid-binding protein, liver
Modified residue 78 – 78 N6-succinyllysine
Modified residue 90 – 90 N6-succinyllysine
Modified residue 100 – 100 Phosphoserine
Beta strand 90 – 95


Literature citations

Human liver fatty acid binding protein. Isolation of a full length cDNA and comparative sequence analyses of orthologous and paralogous proteins.
Lowe J.B.; Boguski M.S.; Sweetser D.A.; Elshourbagy N.A.; Taylor J.M.; Gordon J.I.;
J. Biol. Chem. 260:3413-3417(1985)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT ALA-94;

Human FABP1 T94A variant enhances cholesterol uptake.
Huang H.; McIntosh A.L.; Landrock K.K.; Landrock D.; Storey S.M.; Martin G.G.; Gupta S.; Atshaves B.P.; Kier A.B.; Schroeder F.;
Biochim. Biophys. Acta 1851:946-955(2015)
Cited for: FUNCTION; CHARACTERIZATION OF VARIANT ALA-94;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.